Found 35 matching trials
Adaptive COVID-19 Treatment Trial 2 (ACTT-2)
PHASE3ACTT-2 will evaluate the combination of baricitinib and remdesivir compared...
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19
PHASE2This is a platform trial to conduct a series of randomized, double-blind, p...
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
AGILE (Early Phase Platform Trial for COVID-19)
PHASE1The AGILE platform master protocol allows incorporation of a range of ident...
Location
Desmond Tutu Health Foundation
Adaptive COVID-19 Treatment Trial (ACTT)
PHASE3This study is an adaptive, randomized, double-blind, placebo-controlled tri...
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Adaptive COVID-19 Treatment Trial 4 (ACTT-4)
PHASE3ACTT-4 will evaluate the combination of baricitinib and remdesivir compared...
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients
PHASE3This is a randomized, multicenter, placebo-controlled, double-blind clinica...
Location
PharmaTex Research, LLC
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
PHASE3This is a Phase 3, randomized, actively controlled, double-blinded, double-...
Location
Hope Clinical Research, Inc.
Phase 2a MIB-626 vs. Placebo COVID-19
PHASE2The proposed phase 2a trial will determine whether MIB-626 treatment in adu...
Location
The Brigham and Women's Hospital
AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
PHASE3This study looks at the safety and effectiveness of AZD7442 in treating COV...
Location
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue
Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.
PHASE2Given its anti-viral, anti-oxidative, immune-enhancing, cytokine-modulating...
Location
CHRISTUS Good Shepherd Medical Center